Proceedings: Further studies on the mechanisms of blood pressure lowering effect of L-DOPA and a peripheral decarboxylase inhibitor in hypertensive rats.
D000818:Animals; D000959:Antihypertensive Agents; D001545:Benserazide / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D003900:Desoxycorticosterone; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004558:Electric Stimulation; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D008297:Male; D009392:Nephrectomy; D009638:Norepinephrine / Q000032:analysis; D010646:Phentolamine / Q000494:pharmacology
D000959:Antihypertensive Agents; D003900:Desoxycorticosterone; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D002262:Carboxy-Lyases; D009638:Norepinephrine; D010646:Phentolamine